China-based Eyebright Medical Technology (Beijing) Co., Ltd. (SHA: 688050) has announced that it has received a Class III Medical Devices Certificate from the National Medical Products Administration (NMPA) for its phakic intraocular lens, Loong Crystal PR. The approval, granted with fast-track status, allows the product to be used for treating adult patients with crystalline lens eyes, providing effective correction or reduction of myopia ranging from -3.25D to -18.00D.
Product Features and Benefits
The Loong Crystal PR is constructed from an advanced balanced acrylic material and incorporates a zero spherical aberration design with a large optical zone and a double concave stable arch height structure. Upon implantation, it functions as a refractive element, significantly improving visual acuity and delivering high-quality postoperative results. This innovative design ensures optimal performance and patient satisfaction.
Significance of the Approval
The NMPA approval of Loong Crystal PR marks a significant milestone for Eyebright Medical, expanding its product offerings in the ophthalmic market. This development highlights the company’s commitment to providing advanced solutions for myopia correction, enhancing the treatment options available for patients with varying degrees of myopia.-Fineline Info & Tech
Leave a Reply